ABSTRACT
At this time, clinicians should avoid drawing associations between COVID-19 and GBS, but should remain vigilant in their practice, especially in recently immunized patients. Two patients in the Johnson and Johnson COVID-19 vaccine trial developed GBS, however one of these was in the placebo group. B Introduction: b Guillain Barre Syndrome (GBS) is an acute, autoimmune peripheral neuropathy resulting in paralysis. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)